ArmorMax and LVR, leading providers of refractory solutions, are proud to announce the opening of their new facility in Columbia, South Carolina. This strategic expansion aims to better serve the ...

The following press release was distributed by the American Society for Radiation Oncology (ASTRO)Phase 2 clinical trial ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...

As such, players can start pre-farming Kinich's ascension materials to prepare for his arrival. This article lists all of Kinich's ascension and talent materials in Genshin Impact and their ...

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

Poseida’s partnerships with Roche and Astellas aim to advance CAR-T therapies. See PSTX stock details and the impact of ...

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

September 30, 2024) In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a ...

Global Dry Ramming Mass Market is valued at approximately USD 2.15 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.8% during the forecast period 2023-2030. Read ...

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with ...

The conversion price of the convertible notes will be US$9.06 per ADR (American Depository Receipt) equivalent to A$1.32 per ASX-listed share, representing a 25% premium to Mesoblast’s 5-day volume ...